×
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
NASDAQ:NEOG

Neogen Stock Forecast, Price & News

$24.27
+0.23 (+0.96%)
(As of 06/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$23.77
$24.30
50-Day Range
$22.65
$29.50
52-Week Range
$22.12
$47.80
Volume
646,598 shs
Average Volume
559,219 shs
Market Capitalization
$2.62 billion
P/E Ratio
52.76
Dividend Yield
N/A
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

NEOG Stock Forecast (MarketRank)

Overall MarketRank

1.38 out of 5 stars

Medical Sector

1115th out of 1,432 stocks

Diagnostic Substances Industry

18th out of 27 stocks

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
Neogen logo

About Neogen (NASDAQ:NEOG)

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

NEOG Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:NEOG
CUSIP
64049110
Employees
1,841
Year Founded
1982

Company Calendar

Last Earnings
12/21/2021
Today
6/29/2022
Next Earnings (Estimated)
7/19/2022
Fiscal Year End
5/31/2023

Profitability

Net Income
$60.88 million
Pretax Margin
11.94%

Debt

Sales & Book Value

Annual Sales
$468.46 million
Cash Flow
$0.75 per share
Book Value
$7.85 per share

Miscellaneous

Free Float
107,257,000
Market Cap
$2.62 billion
Optionable
Optionable
Beta
0.60

Social Links















Neogen Frequently Asked Questions

How has Neogen's stock performed in 2022?

Neogen's stock was trading at $45.41 at the beginning of the year. Since then, NEOG shares have decreased by 46.6% and is now trading at $24.27.
View the best growth stocks for 2022 here
.

When is Neogen's next earnings date?

Neogen is scheduled to release its next quarterly earnings announcement on Tuesday, July 19th 2022.
View our earnings forecast for Neogen
.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) issued its quarterly earnings results on Tuesday, December, 21st. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.17 by $0.07. The business had revenue of $130.50 million for the quarter, compared to the consensus estimate of $129.06 million. Neogen had a net margin of 9.55% and a trailing twelve-month return on equity of 7.51%. The company's revenue was up 13.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.15 EPS.
View Neogen's earnings history
.

When did Neogen's stock split? How did Neogen's stock split work?

Shares of Neogen split before market open on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly issued shares were issued to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of Neogen stock prior to the split would have 133 shares after the split.

Who are Neogen's key executives?

Neogen's management team includes the following people:
  • Mr. John Edward Adent, Pres, CEO & Director (Age 54, Pay $844.43k)
  • Mr. Steven J. Quinlan, VP & CFO (Age 60, Pay $381.33k) (LinkedIn Profile)
  • Mr. Douglas E. Jones, COO, VP & Chief Commercial Officer (Age 51, Pay $474.62k)
  • Sarah Demey, Admin. Mang.
  • Ms. Amy M. Rocklin Ph.D., VP, Gen. Counsel & Corp. Sec. (Age 50)
  • Ms. Julie A. Mann, VP & Chief HR Officer (Age 57)

What is John Adent's approval rating as Neogen's CEO?

31 employees have rated Neogen CEO John Adent on Glassdoor.com. John Adent has an approval rating of 56% among Neogen's employees. This puts John Adent in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include NVIDIA (NVDA), NIKE (NKE), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Boeing (BA), JPMorgan Chase & Co. (JPM), W. P. Carey (WPC), Advanced Micro Devices (AMD) and Costco Wholesale (COST).

What is Neogen's stock symbol?

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

How do I buy shares of Neogen?

Shares of NEOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Neogen's stock price today?

One share of NEOG stock can currently be purchased for approximately $24.27.

How much money does Neogen make?

Neogen (NASDAQ:NEOG) has a market capitalization of $2.62 billion and generates $468.46 million in revenue each year. The company earns $60.88 million in net income (profit) each year or $0.46 on an earnings per share basis.

How many employees does Neogen have?

Neogen employs 1,841 workers across the globe.

When was Neogen founded?

Neogen was founded in 1982.

How can I contact Neogen?

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The official website for Neogen is www.neogen.com. The company can be reached via phone at (517) 372-9200, via email at [email protected], or via fax at 517-372-2006.

This page (NASDAQ:NEOG) was last updated on 6/30/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.